Literature DB >> 15084469

Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice.

Henry Mok1, Jaroslav Jelinek, Sonia Pai, Bruce M Cattanach, Josef T Prchal, Hagop Youssoufian, Armin Schumacher.   

Abstract

Coding region mutations in the principal basolateral iron transporter of the duodenal enterocyte, ferroportin 1 (FPN1), lead to autosomal dominant reticuloendothelial iron overload in humans. We report the positional cloning of a hypermorphic, regulatory mutation in Fpn1 from radiation-induced polycythaemia (Pcm) mice. A 58 bp microdeletion in the Fpn1 promoter region alters transcription start sites and eliminates the iron responsive element (IRE) in the 5' untranslated region, resulting in increased duodenal and hepatic Fpn1 protein levels during early postnatal development. Pcm mutants, which are iron deficient at birth, exhibited increased Fpn1-mediated iron uptake and reticuloendothelial iron overload as young adult mice. Additionally, Pcm mutants displayed an erythropoietin (Epo)-dependent polycythemia in heterozygotes and a hypochromic, microcytic anemia in homozygotes. Interestingly, both defects in erythropoiesis were transient, correcting by young adulthood. Delayed upregulation of the negative hormonal regulator of iron homeostasis, hepcidin (Hamp), during postnatal development correlates strongly with profound increases in Fpn1 protein levels and polycythemia in Pcm heterozygotes. Thus, our data suggest that a Hamp-mediated regulatory interference alleviates the defects in iron homeostasis and transient alterations in erythropoiesis caused by a regulatory mutation in Fpn1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084469     DOI: 10.1242/dev.01081

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  25 in total

1.  l7Rn6 encodes a novel protein required for clara cell function in mouse lung development.

Authors:  Rodrigo Fernández-Valdivia; Ying Zhang; Sonia Pai; Michael L Metzker; Armin Schumacher
Journal:  Genetics       Date:  2005-09-12       Impact factor: 4.562

2.  Corticosteroid-regulated genes in rat kidney: mining time series array data.

Authors:  Richard R Almon; William Lai; Debra C DuBois; William J Jusko
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-06-28       Impact factor: 4.310

Review 3.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

4.  Evidence for the multimeric structure of ferroportin.

Authors:  Ivana De Domenico; Diane McVey Ward; Giovanni Musci; Jerry Kaplan
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

Review 5.  Iron overload due to mutations in ferroportin.

Authors:  Ivana De Domenico; Diane McVey Ward; Giovanni Musci; Jerry Kaplan
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

Review 6.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

7.  Severe iron overload with a novel aminolevulinate synthase mutation and hepatitis C infection. A case report.

Authors:  Pauline Lee; Lawrence Rice; John J McCarthy; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2008-09-26       Impact factor: 3.039

8.  Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia.

Authors:  Argel Aguilar-Valles; Cecilia Flores; Giamal N Luheshi
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

9.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11

Review 10.  Iron-regulatory proteins: molecular biology and pathophysiological implications.

Authors:  Gaetano Cairo; Stefania Recalcati
Journal:  Expert Rev Mol Med       Date:  2007-12-05       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.